Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. Financial Results: Neuland
Neuland Laboratories Limited
-(NEULANDLAB)
XNSE:NEULANDLAB, XBOM:NEULANDLAB
Neuland Laboratories Ltd Q1FY24; 520% rise in Profits
Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. Financial Results: Neuland
Neuland Laboratories Limited (NEULANDLAB) Q4 FY23 Earnings Concall Transcript
Neuland Laboratories Limited (NSE:NEULANDLAB) Q4 FY23 Earnings Concall dated May. 11, 2023. Corporate Participants: Ravi Udeshi -- Investor Relations Abhijit Majumdar. -- Chief Financial Officer Saharsh
Neuland Laboratories Q4FY23 Earnings Story
Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. Financial Results: Neuland
Neuland Laboratories Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Neuland Laboratories Limited (NEULANDLAB) Q3 FY23 Earnings Concall Management Update: [00:05:35] NEULANDLAB said its raw material prices are becoming
Neuland Laboratories Limited (NEULANDLAB) Q3 FY23 Earnings Concall Transcript
Neuland Laboratories Limited (NSE:NEULANDLAB) Q3 FY23 Earnings Concall dated Feb. 14, 2023. Corporate Participants: Abhijit Majumdar -- Chief Financial Officer Saharsh Davuluri -- Vice Chairman and
Neuland Laboratories Limited Q4 FY22 Earnings Conference Call Insights
https://youtu.be/SoKfArytP_s Key highlights from Neuland Laboratories Limited (NEULANDLAB) Q4 FY22 Earnings Concall Management Update: NEULANDLAB said its capex plan is on track